Academic Journal
Q1Carcinogenesis
About Carcinogenesis
About Carcinogenesis
Carcinogenesis is a peer-reviewed scholarly journal published by Oxford University Press (United Kingdom). It focuses on Q1. Publication coverage spans 1980-2026.
Key indicators: ISSN 0143-3334, 1460-2180; H-index 230.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (230): Exceptionally high — 230 articles have each been cited at least 230 times. This indicates deep, sustained influence in the field.
Publishing in Carcinogenesis
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Carcinogenesis?
0143-3334, 1460-2180.
Who publishes Carcinogenesis?
Oxford University Press.
What are Carcinogenesis's metrics?
H-index 230.
Where do I submit to Carcinogenesis?
Via the official website.
Is Carcinogenesis peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Carcinogens and Genotoxicity Assessment; DNA Repair Mechanisms; Genomics, phytochemicals, and oxidative stress; Epigenetics and DNA Methylation; Cancer-related Molecular Pathways; Glutathione Transferases and Polymorphisms.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,835.00 USD
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
The Tumour Neurotone: neurochemical regulation of cancer progression and therapy
Isaac Aguirre-Maldonado, Josué Jonatan Pichardo-Espino, Julio Isael Pérez-Carreón, Alfonso Alexander-Aguilera et al.
2026-10-09 · DOI: 10.1093/carcin/bgag076Retraction Notice: STAT3 induces anoikis resistance, promotes cell invasion and metastatic potential in pancreatic cancer cells
2026-09-09 · DOI: 10.1093/carcin/bgag064Retraction Notice: Hepatocyte growth factor-activated NF-KB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines
2026-09-09 · DOI: 10.1093/carcin/bgag061PHB2 Promotes Glycolytic Reprogramming in Triple-Negative Breast Cancer Through FOXM1-Dependent Activation of LDHB
Zankai Wu, Shanshan Wang, Qingfeng Yang, Yiping Gong et al.
2026-09-08 · DOI: 10.1093/carcin/bgag066Retraction of: Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells
2026-08-12 · DOI: 10.1093/carcin/bgag045Retraction of: HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-κB
2026-08-12 · DOI: 10.1093/carcin/bgag046The P2X7 Receptor in Cancer: From Functional Receptor to Non-Functional P2X7
Luyao Liu, Yoshiteru Kagawa, Colin L Masters, Stanley S Stylli et al.
2026-08-06 · DOI: 10.1093/carcin/bgag050Editor's Note: FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells
2026-08-05 · DOI: 10.1093/carcin/bgag042Correction: Role of C9orf140 in the promotion of colorectal cancer progression and mechanisms of its upregulation via activation of STAT5, β-catenin and EZH2
2026-08-05 · DOI: 10.1093/carcin/bgag036Editor's Note: Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer
2026-08-05 · DOI: 10.1093/carcin/bgag023Expression of Concern: The interplay between hypoxia, endothelial and melanoma cells regulates vascularization and cell motility through endothelin-1 and vascular endothelial growth factor
2026-08-05 · DOI: 10.1093/carcin/bgag048Retraction: miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1
2026-07-29 · DOI: 10.1093/carcin/bgag041TGF-β1 and TGF-β2 family members differentially modulate tumor initiation and invasiveness of primary liver cancer in a MMP14-dependent manner
Darko Castven, Sharon Pereira, Luis Z Rodriguez, Merle E Fischer et al.
2026-06-03 · DOI: 10.1093/carcin/bgag037Role of P450 enzymes of the Cyp2abfgs gene subfamilies in tobacco smoke-induced lung tumorigenesis in mice
Lisa M Tran, Patricia C Edwards, Weizhu Yang, Qing-Yu Zhang et al.
2026-03-19 · DOI: 10.1093/carcin/bgag017Fueling early tumorigenesis: interplay between the exposome, obesity-driven metabolic dysfunction and early-onset colorectal and breast cancer
Mansi Upadhyay, Arianna V Bastian, Thomas D Cardaci, Minjeong Kim et al.
2026-07-07 · DOI: 10.1093/carcin/bgag063The prevalence of the AR-V7 variant and its association with clinicopathologic characteristics in non-prostatic cancers—a systematic review
Zaineh Alnoubani, Youssuf Khanafer, Adnan Fojnica, Emir Begagic et al.
2026-07-07 · DOI: 10.1093/carcin/bgag052Correction to: Arsenic disulfide synergizes with the phosphoinositide 3-kinase inhibitor PI-103 to eradicate acute myeloid leukemia stem cells by inducing differentiation
2026-04-09 · DOI: 10.1093/carcin/bgag018Current progress of CDC20 in cancer development and targeting CDC20 for cancer therapy
Yingtong Chen, Shuang Gao, Ping Yang, Shuozi Liu et al.
2026-04-09 · DOI: 10.1093/carcin/bgag021ADH1B–ALDH2 genotype combinations, age-related risk, and field cancerization in head and neck and upper GI cancer screening in 10 073 alcohol-dependent men
Akira Yokoyama, Tai Omori, Tetsuji Yokoyama
2026-07-07 · DOI: 10.1093/carcin/bgag034Ultra-processed foods and breast cancer: epidemiology, mechanisms, and prognostic implications
Xiaying Kuang, Zhongyao Li, Fang Fang Zhang, Andrea Romanos-Nanclares et al.
2026-07-07 · DOI: 10.1093/carcin/bgag062Reviews
Community Reviews
Version History
October 9, 2026 at 9:07 pm
October 2, 2026